Macular degeneration: open trials in Canada

10 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Retina Centre of Ottawa, Ottawa · Centre hospitalier universitaire de Québec -Université Laval, Québec
Registry updated 2026-11-05
NCT07917715
MacuMira Microcurrent Stimulation for Dark Adaptation in Dry Age-Related Macular Degeneration
Trial Treatment · Clarity Eye Institute
Clarity Eye Newmarket, Newmarket · Clarity Eye Scarborough, Scarborough Village · Clarity Eye Vaughan, Vaughan
Registry updated 2026-11-04
NCT06635148
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Alberta Retina Consultants, Edmonton
Registry updated 2026-11-03
NCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Trial Treatment · Phase 3 · AbbVie
Retina Centre of Ottawa /ID# 263803, Ottawa
Registry updated 2026-10-29
NCT07441642
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
London · Ottawa
Registry updated 2026-10-13
NCT06659445
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Trial Treatment · Phase 2 · ONL Therapeutics
Clinique d'ophtalmologie des Laurentides, Boisbriand · St. Joseph's Health Care London - Ivey Eye Institute, London · Toronto Western Hospital, University Health Network, Toronto · Toronto Retina Institute, Toronto
Registry updated 2026-09-10
NCT06990269
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Edmonton · London · Ottawa · Toronto · Vancouver
Registry updated 2026-09-03
NCT06765980
A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Trial Treatment · Phase 1/2 · Kriya Therapeutics, Inc.
Ottawa
Registry updated 2026-08-10
NCT04762368
Learning Study: Improving Vision in Adults With Macular Degeneration
Trial Treatment · University of Waterloo
University of Waterloo, Waterloo
Registry updated 2026-01-22
NCT07129239
High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)
Trial Treatment · Phase 3 · Clinique de Retine de l'est
Clinique de Retine de L'Est, Montreal
Registry updated 2025-08-19

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error